Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 751 AL 765

Pyroptosis in neurodegenerative diseases: from bench to bedside

Wu KJ, Wang WR, Cheng QH, Li H, Yan WZ, Zhou FR, Zhang RJ.

Cell Biol Toxicol. 2023 Dec;39(6):2467-2499. doi: 10.1007/s10565-023-09820-x. Epub 2023 Jul 26.

The role of the CD8+ T cell compartment in ageing and neurodegenerative disorders

Terrabuio E, Zenaro E, Constantin G.

Front Immunol. 2023 Jul 28;14:1233870. doi: 10.3389/fimmu.2023.1233870. eCollection 2023.

Role of NLRP3 inflammasome-mediated neuronal pyroptosis and neuroinflammation in neurodegenerative diseases

Han YH, Liu XD, Jin MH, Sun HN, Kwon T.

Inflamm Res. 2023 Sep;72(9):1839-1859. doi: 10.1007/s00011-023-01790-4. Epub 2023 Sep 19.

The molecular landscape of neurological disorders: insights from single-cell RNA sequencing in neurology and neurosurgery

Awuah WA, Ahluwalia A, Ghosh S, Roy S, Tan JK, Adebusoye FT, Ferreira T, Bharadwaj HR, Shet V, Kundu M, Yee ALW, Abdul-Rahman T, Atallah O.

Eur J Med Res. 2023 Nov 16;28(1):529. doi: 10.1186/s40001-023-01504-w.

Oxygen Sensing in Neurodegenerative Diseases: Current Mechanisms, Implication of Transcriptional Response, and Pharmacological Modulation

Rey F, Messa L, Maghraby E, Casili G, Ottolenghi S, Barzaghini B, Raimondi MT, Cereda C, Cuzzocrea S, Zuccotti G, Esposito E, Paterniti I, Carelli S.

Antioxid Redox Signal. 2023 Jan;38(1-3):160-182. doi: 10.1089/ars.2022.0046.

Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease

Li L, Zhang J, Huang X, Du J, Tu Z, Wu H, Liu X, Yuan M.

Curr Pharm Des. 2023;29(2):95-115. doi: 10.2174/1381612829666221216114912.

Targeting the gut-microbiota-brain axis in irritable bowel disease to improve cognitive function - recent knowledge and emerging therapeutic opportunities

Tang H, Chen X, Huang S, Yin G, Wang X, Shen G.

Rev Neurosci. 2023 Feb 10;34(7):763-773. doi: 10.1515/revneuro-2022-0155. Print 2023 Oct 26.

The theoretical problems of "prodrome" and "phenoconversion" in neurodegeneration

Sturchio A, Espay AJ.

Handb Clin Neurol. 2023;192:155-167. doi: 10.1016/B978-0-323-85538-9.00002-X.

Current and Future Nano-Carrier-Based Approaches in the Treatment of Alzheimer's Disease

Kumar A, Sudevan ST, Nair AS, Singh AK, Kumar S, Jose J, Behl T, Mangalathillam S, Mathew B, Kim H.

Brain Sci. 2023 Jan 27;13(2):213. doi: 10.3390/brainsci13020213.

Silk fibroin carriers with sustained release capacity for treating neurological diseases

Huang X, An Y, Yuan S, Chen C, Shan H, Zhang M.

Front Pharmacol. 2023 May 5;14:1117542. doi: 10.3389/fphar.2023.1117542. eCollection 2023.

Monoclonal antibodies for the management of central nervous system diseases: clinical success and future strategies

Singh Gautam A, Pandey SK, Lasure V, Dubey S, Singh RK.

Expert Opin Biol Ther. 2023 Jul-Dec;23(7):603-618. doi: 10.1080/14712598.2023.2227378. Epub 2023 Jun 27.

Race and Ethnicity in Lewy Body Dementia: A Narrative Review

Bayram E, Holden SK, Fullard M, Armstrong MJ; Lewy Body Dementia Association Community Engagement Working Group.

J Alzheimers Dis. 2023;94(3):861-878. doi: 10.3233/JAD-230207.

Dual role of autophagy for advancements from conventional to new delivery systems in cancer

Mehta P, Shende P.

Biochim Biophys Acta Gen Subj. 2023 Oct;1867(10):130430. doi: 10.1016/j.bbagen.2023.130430. Epub 2023 Jul 26.

Retinal electrophysiology in central nervous system disorders. A review of human and mouse studies

Constable PA, Lim JKH, Thompson DA.

Front Neurosci. 2023 Aug 2;17:1215097. doi: 10.3389/fnins.2023.1215097. eCollection 2023.

A case report of a patient with primary familial brain calcification with a PDGFRB genetic variant

Al Ali J, Yang J, Phillips MS, Fink J, Mastrianni J, Seibert K.

Front Neurol. 2023 Sep 14;14:1235909. doi: 10.3389/fneur.2023.1235909. eCollection 2023.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias